Before you sell to, join or invest in Sea Pharmaceuticals, LLC
MentionFox check on Sea Pharmaceuticals, LLC: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/sea-pharmaceuticals-llc-form-d-25000001
Check Sea Pharmaceuticals, LLC before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Sea Pharmaceuticals, LLC?
Based on the records MentionFox holds for this company. No flag is not a clearance.
Sea Pharmaceuticals, LLC filed an amended Form D with the Securities and Exchange Commission on 2025-05-14.
Sea Pharmaceuticals, LLC filed an amended Form D notice of an exempt securities offering with the SEC on May 14, 2025. The filing reports $71K sold. Its industry group is Pharmaceuticals. It names James Pearson (President, Chief Executive Officer, Chief Science Officer), Walter Brown (Director), Eric Olson (Director) (SEC Form D/A, May 14, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Sea Pharmaceuticals, LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Sea Pharmaceuticals, LLC.
Free to see. No signup.
More on the people and the money behind Sea Pharmaceuticals, LLC, from the filings we hold.
Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.
Get an email when Sea Pharmaceuticals, LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Sea Pharmaceuticals, LLC raises, hires or launches. No email unless you switch it on.
Watch Sea Pharmaceuticals, LLC →Get the full cited report on Sea Pharmaceuticals, LLC
What the filing shows about Sea Pharmaceuticals, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Sea Pharmaceuticals, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Sea Pharmaceuticals, LLC's address as 14 Gray Street, Cambridge, MA 02138.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Sea Pharmaceuticals, LLC →
Amended on 2026-05-20: the amount sold changed from $0 to $71,100; the number of investors changed from 0 to 7. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Sea Pharmaceuticals, LLC See pricing
Sea Pharmaceuticals, LLC is a registered filer with the SEC (CIK 1667677) and has filed since 2023-01-26. 5 filings are on record, the latest on 2026-05-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Sea Pharmaceuticals, LLC's Form D of 2025-05-14 names James Pearson, Walter Brown, Eric Olson and 4 more as its officers, directors or promoters.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Payment of Ordinary Salary
Checked away from the filing. What is below does not come from the record on sec.gov.
Sea Pharmaceuticals LLC is a neurotherapeutics R&D company in Cambridge, Massachusetts developing oral treatments for tinnitus, epilepsy, and sporadic ALS.
The title and description the site itself served, answering 200, after redirecting from https://seapharmaceuticals.com. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
James Pearson is named as President, Chief Executive Officer, Chief Science Officer on the Form D that Sea Pharmaceuticals, LLC filed with the SEC on 14 May 2025, one of 7 people that filing names.
Walter Brown is named as Director on the Form D that Sea Pharmaceuticals, LLC filed with the SEC on 14 May 2025, one of 7 people that filing names.
Eric Olson is named as Director on the Form D that Sea Pharmaceuticals, LLC filed with the SEC on 14 May 2025, one of 7 people that filing names.
Michael Higgins is named as Director on the Form D that Sea Pharmaceuticals, LLC filed with the SEC on 14 May 2025, one of 7 people that filing names.
Nabil Elkouh is named as Director on the Form D that Sea Pharmaceuticals, LLC filed with the SEC on 14 May 2025, one of 7 people that filing names.
Shaker Sadasivam is named as Director on the Form D that Sea Pharmaceuticals, LLC filed with the SEC on 14 May 2025, one of 7 people that filing names.
Mark Currie is named as Director on the Form D that Sea Pharmaceuticals, LLC filed with the SEC on 14 May 2025, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2025-05-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Sea Pharmaceuticals, LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Sea Pharmaceuticals, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sea Pharmaceuticals, LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Sea Pharmaceuticals, LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind Sea Pharmaceuticals, LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-03 (seapharmaceuticals.com).
Each opens in a new tab, filled in for Sea Pharmaceuticals, LLC. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/sea-pharmaceuticals-llc-form-d-25000001